| P2093 | author name string | Bojana Zupan | |
| | Miklos Toth | |
| | Steven Gross | |
| | Ji-eun Oh | |
| P2860 | cites work | Determination of fluoxetine and its metabolite norfluoxetine in serum and brain areas using high-performance liquid chromatography with ultraviolet detection | Q48456679 |
| | Caudal pontine reticular formation of C57BL/6J mice: responses to startle stimuli, inhibition by tones, and plasticity | Q48470218 |
| | Neural stem cell proliferation is decreased in schizophrenia, but not in depression. | Q48686220 |
| | Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. | Q49133564 |
| | Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study | Q50948382 |
| | Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability. | Q52000245 |
| | Regulation of hippocampal neurogenesis in adulthood. | Q52163315 |
| | Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection | Q68097361 |
| | Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy | Q74317868 |
| | Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry | Q24610274 |
| | Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA | Q24615066 |
| | Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior | Q24679793 |
| | Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities | Q27300825 |
| | A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study | Q28249891 |
| | Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 |
| | Auditory cortical plasticity: a comparison with other sensory systems. | Q30321835 |
| | Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine | Q30531104 |
| | Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. | Q34010837 |
| | Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. | Q34317900 |
| | Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial | Q34341755 |
| | Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice | Q34363151 |
| | Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. | Q34586631 |
| | Childhood and adolescent depression: a review of the past 10 years. Part I. | Q34736609 |
| | Do animal models of anxiety predict anxiolytic-like effects of antidepressants? | Q34803577 |
| | The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review | Q35071470 |
| | The economic burden of depression and the cost-effectiveness of treatment. | Q35164226 |
| | Qualitative review of SNRIs in anxiety | Q35985067 |
| | Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test | Q36125183 |
| | Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice | Q36952517 |
| | QTL analysis of multiple behavioral measures of anxiety in mice | Q42620937 |
| | Validation and use of a computer-assisted counting procedure to quantify BrdU-labeled proliferating cells in the early postnatal mouse hippocampus | Q43228579 |
| | Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors | Q43261539 |
| | Serum concentrations of fluoxetine in the clinical treatment setting | Q43569301 |
| | Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult | Q43937540 |
| | Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders | Q43977647 |
| | Fluoxetine pharmacokinetics in pediatric patients | Q44231401 |
| | Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness | Q44660831 |
| | Effects of chronic fluoxetine in animal models of anxiety and depression. | Q44845253 |
| | The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. | Q46266275 |
| | Suicidality in pediatric patients treated with antidepressant drugs | Q46977975 |
| | Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor | Q48206434 |
| | Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats | Q48430698 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluoxetine | Q422244 |
| P304 | page(s) | 2197-2207 | |
| P577 | publication date | 2009-05-13 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Paradoxical anxiogenic response of juvenile mice to fluoxetine | |
| P478 | volume | 34 | |